Zilver Vena Venous Self-Expanding Stent
Cook Ireland, Ltd. · Decision date Apr 14, 2026
What did the FDA decide?
FDA records P200023/S009 as a supplement to PMA P200023, with the supplement type “30-Day Notice”. The recorded decision is OK30 (30-day notice), dated Apr 14, 2026.
FDA approval order statement
add Cook Polymer Technology as an additional supplier of the polytetrafluoroethylene tubing used in the delivery system component
- Regulatory pathway
- PMA supplement
- Supplement type
- 30-Day Notice
- Clinical specialty
- Cardiovascular
- Decision date
- Apr 14, 2026
- FDA change category
- Process Change - Manufacturer/Sterilizer/Packager/Supplier
Regulatory record facts
- Identifier
- P200023/S009
- Regulatory pathway
- PMA supplement
- Applicant
- Cook Ireland, Ltd.
- Product code
- QAN
- Decision code
- OK30
- Decision date
- Apr 14, 2026
- Source update
- Nov 9, 2026
- Original record
- Open FDA source record
About this medical device
FDA device category: Stent, iliac vein.
- Applicant
- Cook Ireland, Ltd.
- Product code
- QAN
- FDA device class
- 3
Review the original FDA PMA listing for the original approval scope and linked supplements.
FDA decision timeline
P200023/S009 received
Application receipt date recorded by FDA.
P200023/S009 · FDA decision
30-Day Notice
Timeline entries are records held by MedtechLedger for P200023. View FDA’s full supplement list.
Related devices and submissions
Explore the linked device profile
Other records with product code QAN
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
Abre Venous Self-expanding Stent SystemP200026/S020 | Medtronic Vascular, Inc. | PMA supplement | Oct 30, 2026 | FDA |
Abre Venous Self-Expanding Stent SystemP200026/S019 | Medtronic Vascular, Inc. | PMA supplement | Oct 16, 2026 | FDA |
Duo Venous Stent SystemP230021/S004 | Philips Image Guided Therapy Corporation | PMA supplement | Aug 26, 2026 | FDA |
Venovo Venous Stent SystemP180037/S015 | Bard Peripheral Vascular, Inc. | PMA supplement | Jun 10, 2026 | FDA |
Abre Venous Self-expanding Stent SystemP200026/S018 | Medtronic Vascular, Inc. | PMA supplement | Apr 27, 2026 | FDA |
A shared product code identifies a classification relationship; it does not establish clinical equivalence.
Regulatory context
A PMA supplement records a change to a device with an existing premarket approval. The supplement’s approval applies to the change described in that submission.
Read our guide to FDA clearance and approval · FDA’s explanation of this pathway
Manufacturer intelligence
Cook Ireland, Ltd.
- Headquarters
- Not reported
- Brand website
- cookmedical.com
- FDA applicant address
- O' Halloran Rd., National Technology Park, Limerick
Sources and methodology
- Original FDA record: P200023/S009
- openFDA source data · Source release Nov 9, 2026 · Retrieved Nov 20, 2026
FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.
How we use FDA records


